h.barros
Submits third-party assay reports on material purchased directly. Based in Łódź.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.87%
n=9
Suppliers covered
9
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042485 | N-Acetyl Semax Amide | Homopeptide | HOMO-2603-C5267 | PeptideMeter | 2026-Q2 | 99.02 | 8.49 | 95.8 | Laboratory-retained | 0 | PASS |
| AX-2026-043565 | Liraglutide | SIG | SIG-2508-6459 | Kestrel | 2026-Q1 | 99.06 | 5.02 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041494 | Semaglutide | QSC | QSC-2509-Y6202 | Kestrel | 2026-Q1 | 99.75 | 5.37 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020276 | Liraglutide | GGPeps | GGPE-2505-W2368 | Janoshik | 2025-Q4 | 98.62 | 6.89 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019094 | SLU-PP-332 | GSP | GSP-2511-C3427 | Medutest | 2025-Q4 | 99.20 | 6.61 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019538 | CJC-1295 (no DAC) | TFC | TFC-2507-C9225 | Janoshik | 2025-Q4 | 98.87 | 6.20 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020489 | BPC-157 | KP | KP-2511-M5901 | VendorInvestigate | 2025-Q4 | 98.56 | 5.03 | 97.1 | Buyer-sourced | 0 | PASS |
| AX-2025-019937 | Semaglutide | HJ | HJ-2507-Y6433 | Janoshik | 2025-Q3 | 98.46 | 3.57 | 95.2 | Buyer-sourced | 0 | PASS |
| AX-2025-019168 | Tirzepatide | SinoPep | SNP-2505-A3973 | PeptideMeter | 2025-Q2 | 98.55 | 4.73 | 102.3 | Buyer-sourced | 0 | PASS |